ZZurich Insurance Read More RiverStone enters Australian market2026-03-19 London-headquartered RiverStone International has announced the establishment of an Australian operation, marked by the acquisition of locally domiciled…
NNovartis Read More Novartis acquires Avidity Biosciences for US$12bn2026-03-16 Novartis AG has agreed to acquire Avidity Biosciences Inc in a US$12bn transaction, set to close in Q1…
NNovartis Read More Novartis’ new drugs outweigh Entresto decline in Q32026-03-09 Novartis’ third-quarter results have exemplified the reason for its recent deal-making activity, as heart failure therapy Entresto finally…
ZZürich Read More Zurich and Beazley reach agreement on M&A deal worth more than US$10bn2026-03-03 The boards of Zurich and Beazley announce that they have agreed the terms of a recommended all-cash offer…
ZZürich Read More Australia: Zurich to acquire Clearview2026-02-25 Zurich Financial Services Australia will acquire ClearView Wealth (ClearView) through a scheme of arrangement. ClearView is the parent…
ZZürich Read More ClearView to be acquired by Zurich2026-02-24 ClearView Wealth has agreed to be acquired by Zurich Financial Services. On 24 February, the two firms announced they had entered…
NNestlé Read More Nestlé proposes Ma. Fatima D. Francisco and Thomas Jordan for election to its Board of Directors; updates its governance practices2026-02-18 [Ad hoc announcement pursuant to Art. 53 LR] This press release is also available in Français (pdf) and…
NNovartis Read More Novartis nabs cardio drug with $1.4bn Tourmaline buy2026-02-17 Novartis has bulked up its cardiology pipeline with a $1.4 billion takeover of Tourmaline Bio and its phase…
ZZurich Insurance Read More Zurich given more time to mull over £8bn takeover of Beazley – London Business News2026-02-16 Insurance giant Zurich has been granted extra time to mull over a jaw-dropping £8 billion takeover of Lloyd’s-listed…
RRoche Read More Roche poised to buy MASH drug developer 89bio for $3.5bn2026-02-15 Roche has dipped its toe in the M&A water with an agreement to buy US biotech 89bio and…
RRoche Read More Roche acquires 89bio for US$3.5bn2026-02-12 Under the agreement, swiss Roche AG will pay US$14.50 per share in cash, equal to an equity value…
GGlencore Read More Glencore shares slide after Rio Tinto merger unravels2026-02-12 Thursday 05 February 2026 4:02 pm Share Facebook Share on Facebook X Share on Twitter LinkedIn Share on…